Myint, Phyo KCarter, BenBarlow-Pay, FenellaShort, RoxannaEinarsson, AliceBruce, EilidhMcCarthy, KathrynVerduri, AlessiaCollins, Jemima THesford, JamesRickard, FrancesMitchell, EmmaHolloway, MarkMcGovern, AineVilches-Moraga, ArturoBraude, PhilipPearce, LyndsayStechman, Michael JPrice, AngelineQuinn, Terence JClini, EnricoMoug, Susan JHewitt, JonathanCOPE Study Collaborators2021-03-082021-03-082021Myint, P K, Carter, B, Barlow-Pay, F, Short, R, Einarsson, A, Bruce, E, McCarthy, K, Verduri, A, Collins, J T, Hesford, J, Rickard, F, Mitchell, E, Holloway, M, McGovern, A, Vilches-Moraga, A, Braude, P, Pearce, L, Stechman, M J, Price, A, Quinn, T J, Clini, E, Moug, S J, Hewitt, J & COPE Study Collaborators 2021, 'Routine Use of Immunosuppressants is Associated with Mortality in Hospitalised Patients with Covid-19', Therapeutic Advances in Drug Safety, vol. 12, 2042098620985690, pp. 1-17. https://doi.org/10.1177/20420986209856902042-0986PubMedCentral: PMC7897811ORCID: /0000-0003-3852-6158/work/163198749https://hdl.handle.net/2164/15993Acknowledgement We acknowledge the dedication, commitment, and sacrifice of the staff from participating centres across UK and Italy, two among the most severely affected countries in Europe. We gratefully acknowledge the contribution of our collaborators, National Institute of Health Research (NIHR), Health Research Authority (HRA) in the UK and Ethics Committee of Policlinico Hospital Modena, which provided rapid approval of COPE study and respective Institutions’ Research and Development Offices and Caldicott Guardians for their assistance and guidance. We also thank COPE Study Sponsor, Cardiff University, Wales, UK.17216921engCoronavirusCovid-19immunosuppressantimmunosuppressionimmunosuppressantsR MedicinePharmacology (medical)Supplementary DataRJournal article10.1177/2042098620985690http://www.scopus.com/inward/record.url?scp=85101275294&partnerID=8YFLogxK12